The Once-Daily Human GLP-1 Analog Liraglutide Reduces the Prevalence of Prediabetes and Improves Systolic Blood Pressure in Obese Non-Diabetic Subjects: A 52-Week, Randomized Placebo-Controlled Trial
Year: 2009
Type: article
Authors: Nick Finer, M Al Hakim, L. Van Gaal, Arne Astrup, Alex Harper, MEJ Lean, Leo Niskanen, MF Rasmussen, A Rissanen, Stephan Rössner, M.J. Savolainen
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W147693175